Barrett esophagus: Need for ongoing surveillance called into question for patients with non-dysplastic Barrett esophagus

@article{Wood2011BarrettEN,
  title={Barrett esophagus: Need for ongoing surveillance called into question for patients with non-dysplastic Barrett esophagus},
  author={Natalie J. Wood},
  journal={Nature Reviews Gastroenterology \&Hepatology},
  year={2011},
  volume={8},
  pages={657-657}
}
  • Natalie J. Wood
  • Published 5 December 2011
  • Medicine
  • Nature Reviews Gastroenterology &Hepatology
Barrett esophagus: Need for ongoing surveillance called into question for patients with non-dysplastic Barrett esophagus 
2 Citations

Epidemiology of Barrett Esophagus and Risk Factors for Progression

  • O. FisherR. Lord
  • Medicine
    Shackelford's Surgery of the Alimentary Tract, 2 Volume Set
  • 2019

Endocytoscopic visualization of squamous cell islands within Barrett's epithelium.

TLDR
This is the first report of in vivo visualization of esophageal papillary squamous cell islands surrounded by glandular Barrett's epithelium in a patient with long-segment Barrett's esophagus.

References

SHOWING 1-2 OF 2 REFERENCES

Incidence of adenocarcinoma among patients with Barrett's esophagus.

TLDR
Barrett's esophagus is a strong risk factor for esophageal adenocarcinoma, but the absolute annual risk, 0.12%, is much lower than the assumed risk of 0.5%, which is the basis for current surveillance guidelines.

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

TLDR
The incidence of OAC in non-dysplastic Barrett's oesophagus in patients with BO without dysplasia is around 1 per 300 patients per year, and the incidence in short-segment BO is under 1 per 500 patients peryear.